Brokerages Set Prestige Consumer Healthcare Inc. (NYSE:PBH) Price Target at $93.33

Key Points

• Prestige Consumer Healthcare Inc. has received a consensus rating of "Hold" from analysts, with one sell recommendation, three holds, and three buy ratings.
• The company's latest quarterly earnings showed an EPS of $0.95, missing analysts' expectations of $1.01, and revenue declined by 6.6% compared to the previous year.
• Prestige Consumer Healthcare's average target price among brokers is $93.33, despite recent downgrades from various research firms.

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) has been given a consensus recommendation of "Hold" by the seven research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $93.3333.

Several research analysts have recently issued reports on the stock. Canaccord Genuity Group reduced their target price on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Wall Street Zen lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, Zacks Research lowered shares of Prestige Consumer Healthcare from a "hold" rating to a "strong sell" rating in a research note on Thursday, September 4th.

Prestige Consumer Healthcare Trading Down 1.7%

Shares of NYSE PBH traded down $1.09 during mid-day trading on Wednesday, hitting $62.16. The company's stock had a trading volume of 84,573 shares, compared to its average volume of 407,542. The stock has a market cap of $3.06 billion, a price-to-earnings ratio of 14.56, a price-to-earnings-growth ratio of 2.00 and a beta of 0.46. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. Prestige Consumer Healthcare has a one year low of $62.71 and a one year high of $90.04. The company's fifty day simple moving average is $70.53 and its 200-day simple moving average is $79.15.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). The business had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The firm's revenue for the quarter was down 6.6% compared to the same quarter last year. During the same period last year, the business posted $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. On average, sell-side analysts anticipate that Prestige Consumer Healthcare will post 4.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Osaic Holdings Inc. boosted its stake in Prestige Consumer Healthcare by 574.5% during the 2nd quarter. Osaic Holdings Inc. now owns 13,226 shares of the company's stock worth $1,056,000 after acquiring an additional 11,265 shares during the last quarter. Orion Porfolio Solutions LLC bought a new position in Prestige Consumer Healthcare during the 2nd quarter worth approximately $204,000. Squarepoint Ops LLC boosted its stake in Prestige Consumer Healthcare by 6.3% during the 2nd quarter. Squarepoint Ops LLC now owns 72,555 shares of the company's stock worth $5,794,000 after acquiring an additional 4,308 shares during the last quarter. State of Wyoming bought a new position in Prestige Consumer Healthcare during the 2nd quarter worth approximately $97,000. Finally, Pitcairn Co. bought a new position in Prestige Consumer Healthcare during the 2nd quarter worth approximately $264,000. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.